Medical Research Awards support early-career scientists studying leukemia, lymphoma, and related blood cancers to advance prevention, detection, and treatment, prioritizing work likely to reach clinical trials.
Funder: Gabrielle's Angel Foundation for Cancer Research
Due Dates (Anticipated): August 2027 (Annual application deadline)
Funding Amounts: $225,000 over three years ($75,000 annually, including 10% indirect costs)
Summary: Supports early-career investigators researching prevention, detection, and treatment of leukemia, lymphoma, and related blood cancers.
Key Information: Invitation-only through NCI-designated institutions; international applications are not currently accepted.
Gabrielle's Angel Foundation for Cancer Research supports early-career scientists conducting research on leukemia, lymphoma, and related cancers of the blood. Its Medical Research Awards fund prevention, detection, and treatment studies, prioritizing work most likely to translate into clinical trials within three to five years. The program supports both conventional scientific research and integrative approaches involving complementary therapies or botanical agents.
Integrative projects may explore evidence-based interventions that improve mainstream care or reduce patients’ physical and emotional distress during or after cancer therapy. Examples include acupuncture, mind-body interventions, massage, meditation, music therapy, nutrition, physical fitness, yoga, and biologically based agents used in nonconventional ways. Both clinical trials and preclinical research may be supported.